Maladaptive Aortic Properties in Children After Palliation of Hypoplastic Left Heart Syndrome Assessed by Cardiovascular Magnetic Resonance Imaging
In children with hypoplastic left heart syndrome, the status of the reconstructed aorta after the Norwood operation is of potential prognostic importance. Dilatation and an impaired distensibility of the neoaorta have already been reported in previous echocardiographic and angiocardiographic studies. However, comprehensive data on the anatomic and functional properties of the reconstructed aorta and their potential influence on right ventricular function in hypoplastic left heart syndrome are still lacking. The present study used cardiovascular magnetic resonance imaging to evaluate the anatomy, bioelastic properties, viability of the aorta and right ventricular ejection fraction in 40 patients with hypoplastic left heart syndrome. Compared with control subjects, patients with hypoplastic left heart syndrome had an increased aortic size and reduced aortic bioelasticity (distensibility and pulse-wave velocity). Fibrosis was detected with cardiovascular magnetic resonance imaging in the proximal aorta using the well-proven late gadolinium enhancement technique. Aortic late gadolinium enhancement correlated inversely with reduced right ventricular ejection fraction and distensibility in the ascending aorta. These findings suggest unfavorable aortic-ventricular coupling, which may contribute to a higher risk for later right ventricular failure. This study may help improve our understanding of aortic biophysical properties after extensive surgical reconstruction of the aorta. The results may serve as baseline data for further longitudinal studies in children with hypoplastic left heart syndrome to establish the prognostic value of anatomic and bioelastic aortic properties measured by cardiovascular magnetic resonance imaging. See p 1068. The prognosis for patients with acute myocardial infarction has been improved by primary percutaneous coronary intervention, especially the implantation of bare-metal stents (BMS) or drug-eluting stents. However, there is an increased frequency of late stent malapposition after drug-eluting stent implantation. In the prospective, multicenter Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, patients with STelevation myocardial infarction within 12 hours of symptom onset were randomized 3:1 to TAXUS EXPRESS paclitaxel-eluting stents (PES) versus EXPRESS BMS. The present intravascular ultrasound substudy included 241 patients with 263 native coronary lesions (201 PES, 62 BMS) with poststenting and 13-month follow-up intravascular ultrasound imaging. Postintervention acute stent malapposition occurred in 34.3% PES-and 40.3% BMS-treated lesions. The reason for resolved acute stent malapposition was negative remodeling with larger acute stent malapposition areas (Ͼ1.2 mm 2 ) separating persistent from resolved acute stent malapposition. At follow-up, a higher frequency of late stent malapposition was detected in PEStreated lesions (46.8%) mainly because of more late acquired stent malappositions (30.8%) compared with BMS-treated lesions. Late acquired stent malapposition was attributable to plaque/thrombus resolution in both BMS and PES and to positive remodeling in PES; the largest areas of late stent malapposition either persisted from implantation or were seen in lesions with positive remodeling. However, the number of events related to stent malapposition was small (with no deaths or stent thrombosis), and follow-up was limited to only 1 year; therefore, longer follow-up is required to determine the relationship of long-term major adverse cardiac events (and especially very late stent thrombosis) and late stent malapposition. See p 1077.
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Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?
Stent thrombosis is a potentially devastating condition that puts all patients undergoing stent implantation at risk. Variability in the presentation and timing of stent thrombosis can make it an unpredictable and challenging issue to address. Our study demonstrates that black race is an independent predictor of stent thrombosis even when accounting for comorbid confounders and socioeconomic status. These findings suggest that particular populations warrant careful attention with regard to the selection of stent type and antiplatelet therapy. The advent of bedside antiplatelet responsiveness testing may help address this concern. In light of these hypothesis-generating results, further pathogenic studies of genomic and environmental influences should be pursued. See p 1085.
Late Outcomes After Carotid Artery Stenting Versus Carotid Endarterectomy: Insights From a Propensity-Matched Analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry
From the 68 236 patients with atherothrombosis enrolled in the Reduction of Atherothrombosis for Continued Health (REACH), we analyzed 3412 patients (5%) who had a history of carotid artery revascularization, 1025 (30%) with carotid artery stenting, and 2387 (70%) with carotid endarterectomy. At the end of 2 years of follow-up, in this real-world cohort of patients, carotid artery stenting was comparable to carotid endarterectomy for late outcomes. The results were consistent in a propensity score-matched model and in a regression model adjusted for propensity score. The Endarterectomy Versus Angioplasty (EVA-3S) and Stent-Supported Percutaneous Angioplasty of the Carotid Artery Versus Endarterectomy (SPACE) trials failed to show noninferiority of carotid artery stenting compared with carotid endarterectomy for 30-day events. However, longer-term follow-up of both of these trials showed that the rates of ipsilateral stroke were low and similar between the 2 groups at 2 and 4 years of follow-up. Similarly, in the recently published Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the long term outcomes were similar. There is thus a need for extended duration of follow-up in studies comparing carotid artery stenting and carotid endarterectomy. See p 1091.
Time in Recurrent Ventricular Fibrillation and Survival After Out-of-Hospital Cardiac Arrest
Ventricular fibrillation (VF) frequently recurs after initial defibrillation for out-of-hospital cardiac arrest. To minimize interruptions in chest compressions during cardiopulmonary resuscitation, the 2005 resuscitation guidelines (G2005) advise immediate resumption of cardiopulmonary resuscitation for 2 minutes after a shock, regardless of shock success. Resuscitation guidelines 2000 (G2000) advised a postshock rhythm analysis before resuming cardiopulmonary resuscitation for only 1 minute. Because chest compressions sometimes reinduce VF, we investigated whether patients resuscitated under G2005 spend more time in VF and whether time in VF is related to neurologically intact survival. Patients treated under G2000 and G2005 were compared. Considering the time to initial defibrillation shock, time in initial VF was associated with worse outcome for G2000 but not for G2005. Time with cardiopulmonary resuscitation increased from an average of 60% under G2000 to 74% under G2005. For recurrent VF, under G2005, rescuers delayed repeat defibrillation, and patients spent a longer time in recurrent VF. A longer cumulative duration of recurrent VF was associated with worse outcome. Neurologically intact survival was similar in both guidelines groups. Thus, the additional time in recurrent VF with G2005 may offset the putative benefit of increased cardiopulmonary resuscitation, with a neutral net effect on outcome. Studies of immediate defibrillation for recurrent VF to reduce recurrent VF duration are warranted. See p 1101.
Prevalence, Characteristics, and Outcomes of Patients Presenting With Cardiogenic Unilateral Pulmonary Edema
Cardiogenic bilateral pulmonary edema usually appears on chest x-rays as bilateral and symmetrical opacities, resulting in the classic "butterfly shadow." Cardiogenic unilateral pulmonary edema (UPE) is an unusual entity. Little is known about the characteristics of UPE, and its prevalence has never been assessed in a large series of pulmonary edema. Among a large population with cardiogenic pulmonary edema (nϭ869), we found that the prevalence of the unilateral pattern of cardiogenic pulmonary edema was 2.1%; that UPE was right-sided in 89%, involving mainly the right upper lobe; and that UPE was always associated with severe organic or functional mitral regurgitation. In-hospital mortality of UPE was significantly higher (39% versus 8% in patients with bilateral pulmonary edema). In multivariate analysis, UPE was independently related to death, with a risk of death 6.5-fold higher than in patients with bilateral pulmonary edema. Because of initial misdiagnosis caused by the unilateral location of opacities on chest x-rays, a delay in diagnosis and adequate treatment was observed in 33% of cases. These results have implications in routine practice to best recognize this clinical entity and thus to avoid delay in treatment that may affect prognosis. See p 1109.
Get With The Guidelines-Stroke Performance Indicators: Surveillance of Stroke Care in the Taiwan Stroke Registry: Get With The Guidelines-Stroke in Taiwan
Stroke is a leading cause of death around the world. Improving quality of stroke care is a global priority, despite diverse healthcare economies across nations. The American Heart Association and American Stroke Association have launched a nation-wide drive to improve quality of stroke care and prevention applying the Get With the Guidelines-Stroke (GWTG-Stroke) program. GWTG-Stroke has improved the quality of stroke care in 790 US academic and community hospitals over a period of 5 years (2003) (2004) (2005) (2006) (2007) . These favorable results have broad implications in the United States. Whether GWTG-Stroke is applicable across national and economic boundaries was tested in the Taiwan Stroke Registry with 30 599 stroke admissions. Taiwan spends Ϸ1/10 of what the United States spends in medical costs per new or recurrent stroke. The Taiwan Stroke Registry, sponsored by Taiwan Department of Health and engaging 39 academic and community hospitals, covers the country with 4 steps of quality control to ensure reliability of entered data. Five GWTG-Stroke performance indicators and 1 safety indicator are applied to assess Taiwan Stroke Registry quality of stroke care. Demographic and outcomes figures are comparable between GWTG-Stroke and Taiwan Stroke Registry. Two indicators (early and discharge antithrombotics) are close to GWTG-Stroke standards while 3 others (intravenous tissue plasminogen activator, anticoagulation for atrial fibrillation, lipid-lowering medication) and 1 safety indicator fall behind. Results show that GWTG-Stroke can be the global standard for improving the quality of stroke care outside the Unites States. GWTG-Stroke can be incorporated into national stroke registries around the world. Preliminary analysis shows compliance with selected GWTG-Stroke guidelines is associated with better outcomes. See p 1116.
